2005 Webinar: Institutional Oversight of Human Embryonic Stem Cell Research


This webinar addressed institutional oversight of human embryonic stem cell (hESC) research. Roles of the Institutional Review Board (IRB), Institutional Animal Care and Use Committee (IACUC), Institutional Biosafety Committee (IBC), and the Embryonic Stem Cell Research Oversight Committee (ESCRO), as described by the recent National Academy of Sciences (NAS) Guidelines, were discussed.

The NAS Guidelines are an important next step in the oversight of hESC research. Their call for the creation of local ESCRO Committees will require careful planning with attention to communication and collaboration with existing institutional oversight and the investigator community.

The webinar included experts in the field of research ethics and subject protections. Topics addressed during the seminar included:


The audience for this webinar included those charged with research oversight as well as those engaged in research with stem cells.


  • Jonathan Moreno, PhD, Emily Davie and Joseph S. Kornfeld Professor of Biomedical Ethics at the University of Virginia, and Director, Center for Biomedical Ethics  P. Pearl O’Rourke, MD , Director, Human Research Affairs, Partners HealthCare System, Inc., Boston
  • David Scadden, MD, Professor of Medicine at Harvard Medical School; Director of the Massachusetts General Hospital Center for Regenerative Medicine and Technology; and Co-Director of the Harvard Stem Cell Institute